v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
REVENUE:        
Product revenue, net $ 1,998 $ 2,208 $ 4,427 $ 4,690
COSTS AND EXPENSES:        
Cost of revenue 3,272 3,367 4,215 5,027
Research and development 10,820 9,698 18,256 22,561
Selling, general and administrative 16,202 7,502 26,306 16,812
Asset impairment charges 58,957 58,957
 Total operating expenses 30,294 79,524 48,777 103,357
Operating loss (28,296) (77,316) (44,350) (98,667)
Grant income 1,036 1,959
(Loss) gain on change in fair value of warrant liabilities (855) 6,150
Loss on extinguishment of debt 0 0 (2,092) 0
Interest income, net 943 1 1,571 3
Other expense, net (1,955) (606) (2,189) (1,201)
Net loss available to common stockholders $ (28,272) $ (78,776) $ (45,101) $ (93,715)
Net loss per common share, basic $ (3.86) $ (1,920.85) $ (6.80) $ (2,720.40)
Net loss per common share, diluted $ (3.86) $ (1,920.85) $ (6.80) $ (2,720.40)
Weighted average common shares outstanding, basic 7,327,257 41,011 6,631,111 34,449
Weighted average common shares outstanding, diluted 7,327,257 41,011 6,631,111 34,449

Source